3.3. Isobologram Analysis of Combined Treatment Effects of γ-Tocotrienol with PPARγ Agonists (Rosiglitazone and Troglitazone) and Antagonists (GW9662 and T0070907) on +SA Mammary Tumor Cells. This evidence concerns the gene PPARG and breast cancer.